Maria-Eleni Roumelioti

Learn More
BACKGROUND Although symptoms of sleepiness and fatigue are common in adults with chronic kidney disease (CKD), little is known about the prevalence of these symptoms in children with CKD. STUDY DESIGN Cross-sectional analysis within a cohort study. SETTING & PARTICIPANTS We describe the frequency and severity of sleep problems and fatigue and assess the(More)
BACKGROUND AND OBJECTIVES Sleep-disordered breathing (SDB) and excessive daytime sleepiness (EDS) are highly prevalent among hemodialysis (HD) patients. It is unclear to what extent SDB is associated with advanced chronic kidney disease (CKD; stages 4 to 5). This paper describes and compares the prevalence, severity, and patterns of SDB and EDS among(More)
BACKGROUND/AIMS Little is known about the association of chronic kidney disease (CKD) with sleep quality, mood, and alertness. In this report, we assessed these symptoms among patients with advanced CKD (stages 4-5) and those with end-stage renal disease (ESRD) and compared them to healthy controls without known kidney disease. METHODS Patients were(More)
BACKGROUND Dialysis patients and patients with chronic kidney disease (CKD) experience a substantial risk for abnormal autonomic function and abnormal heart rate variability (HRV). It remains unknown whether HRV changes across sleep stages in patients with different severity of CKD or dialysis dependency. We hypothesized that high-frequency (HF) HRV (vagal(More)
Obstructive sleep apnea (OSA) is common, underdiagnosed, and undertreated among patients with end-stage renal disease (ESRD). As in all cases, pathogenesis of OSA is related to repeated upper airway (UA) occlusion or narrowing, but in ESRD, additional contributory factors likely include uremic destabilization of central respiratory control and anatomic(More)
This update summarizes 8 important studies in nephrology, transplantation, and hypertension that are relevant to primary care. The authors screened the literature by using ACP JournalWise to identify articles for inclusion and subsequently considered additional late-breaking publications. Studies were selected to emphasize the provision of high-value care(More)
BACKGROUND The bulk of randomized trial evidence for the expanding use of High Flux (HF) hemodialysis worldwide comes from two randomized controlled trials, one of which (HEMODIALYSIS, HEMO) allowed, while the other (Membrane Outcomes Permeability, MPO) excluded, the reuse of membranes. It is not known whether dialyzer reuse has a differential impact on(More)
There is currently an unmet need for better biomarkers across the spectrum of renal diseases. In this paper, we revisit the role of beta-2 microglobulin (β2M) as a biomarker in patients with chronic kidney disease and end-stage renal disease. Prior to reviewing the numerous clinical studies in the area, we describe the basic biology of β2M, focusing in(More)
Vascular instability and severe episodes of intradialytic hypotension (IDH) represent the most frequent (up to 20%) (1) and challenging complications of conventional dialysis regimens (2), resulting in underdialysis and volume expansion (3). In addition, repeated episodes of IDH are uncomfortable for the patient and may causemultisystemmorbidity and(More)
BACKGROUND Automated peritoneal dialysis (APD) is one of the fastest growing dialysis modalities. It is unknown whether sleep and mood are disturbed while performing repeated overnight exchanges. OBJECTIVES In this report, we aim to describe and compare the prevalence of sleep-disordered breathing (SDB), periodic limb movements (PLMS), poor sleep quality(More)
  • 1